Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction-Reference-Cited by-同舟云学术

Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction

Published:2021-05 Issue:5 Volume:6 Page:431-443
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

George Marc Jonathan,Jasmin Nur Hayati,Cummings Valerie Taylor,Richard-Loendt Angela,Launchbury Francesca,Woollard Kevin,Turner-Stokes Tabitha,Garcia Diaz Ana Isabel,Lythgoe Mark,Stuckey Daniel James,Hingorani Aroon Dinesh,Gilroy Derek William

Funder

Wellcome Trust

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Epidemiology and aetiology of heart failure;Ziaeian;Nat Rev Cardiol,2016

2. Interleukin-6 and the risk of adverse outcomes in patients after an acute coronary syndrome: observations from the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) trial;Fanola;J Am Heart Assoc,2017

3. Monocyte subsets coregulate inflammatory responses by integrated signaling through TNF and IL-6 at the endothelial cell interface;Chimen;J Immunol,2017

4. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment;Romano;Immunity,1997

5. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha;Modur;J Clin Invest,1997

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with preserved ejection fraction: The role of inflammation;European Journal of Pharmacology;2024-10

2. First time ACS in patients with on‐target lipid levels: Inflammation at admission and re‐event rate at follow‐up;European Journal of Clinical Investigation;2024-08-19

3. Obesity Arrhythmias: Role of IL-6 Trans-Signaling;International Journal of Molecular Sciences;2024-08-01

4. Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics;Molecular Biotechnology;2024-07-09

5. The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases;Experimental Hematology & Oncology;2024-06-18